Our goal with CosmeticAI™ was to make cosmetic ingredient development predictable rather than exploratory” — Dr. Lurong Pan, CEO of Ainnocence SAN FRANSICO, CA, UNITED STATES, January 1, 2026 ...

SAN DIEGO, CALIFORNIA / ACCESS Newswire / April 17, 2025 / Bora Biologics is set to showcase its innovative Allosteric Formulation Platform at the Festival of Biologics 2025, demonstrating ...

OKLAHOMA CITY--(BUSINESS WIRE)--Cytovance Biologics, a U.S.-based Contract Development and Manufacturing Organization (CDMO), announced the launch of its in-house formulation development services, ...

Biologics, with their precision targeting, expand treatment options for a multitude of diseases - from cancer to autoimmune disorders. In 2023 alone, 10 antibody therapeutics received their first ...

Adding to its long investment track record across the pharmaceutical supply chain, 3i Group has joined hands with biotech veteran Dr. Hanns-Christian Mahler to launch an integrated but specialized ...

The WuXiHigh™2.0 technology platform harnesses proprietary excipient blends and expertise to enable concentrations up to 230 mg/mL It reduces viscosity by up to 90% while maintaining formulation ...

Not long ago, solving the crystal structure of a protein required an entire PhD. Growing crystals, collecting X-ray diffraction data, and interpreting electron density maps often took years of ...

The "Subcutaneous Biologics Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Biologic, Type of Therapy, End User, Payment Method Employed, Therapeutic Area, Drug Delivery ...